Alchemia Limited (ACL.AX)
-ASX | Prev Close: | 0.37 |
|---|
| Open: | 0.37 |
|---|
| Bid: | 0.36 |
|---|
| Ask: | 0.37 |
|---|
| 1y Target Est: | 0.94 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.36 - 0.37 |
|---|
| 52wk Range: | 0.28 - 0.62 |
|---|
| Volume: | 32,881 |
|---|
| Avg Vol (3m): | 301,750 |
|---|
| Market Cap: | 102.50M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in AUD.
Key Statistics
| Forward P/E (1 yr): | 4.56 |
|---|
| P/S (ttm): | 10.73 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | -0.04 |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Alchemia Limited, a biotechnology company, engages in the discovery and development of human therapeutic products based on its proprietary drug discovery, drug targeting, and synthesis technologies primarily in Australia.
View More 
1.85%